Your Article Summary
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid
Annals of Neurology , 06/29/09
Owens GP et al. - The oligoclonal B-cell response in MS cerebrospinal fluid is not targeted to the well-characterized myelin antigens myelin basic protein, proteolipid protein, or myelin oligodendrocyte glycoprotein.
Related Articles
Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay
Rheumatology, 10/08/09
Relevance Score: 95%
Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity
Rheumatology, 11/20/09
Relevance Score: 94%
Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: A cross-sectional study
Journal of Rheumatology, 11/18/09
Relevance Score: 94%
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study
Arthritis Research & Therapy, 10/16/09
Relevance Score: 94%
Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica
Multiple Sclerosis, 11/18/09
Relevance Score: 91%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP
Epilepsia, 12/05/09
Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease
Brain, 12/05/09
Micro-ribonucleic acid profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
Brain, 12/04/09
Today in Demyelinating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Micro-ribonucleic acid profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
Brain, 12/04/09
Dysregulated Epstein-Barr virus infection in patients with CIDP
Journal of Neuroimmunology, 12/04/09
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/04/09

See Latest Articles